Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease

Clinical Respiratory Journal

Volumn 7, Issue 3, 2013, Pages 281-287

  Kiljander, Toni ^a,b   Rantanen, Tuomo ^c,d   Kellokumpu, Ilmo ^e   Kööbi, Tiit ^c   Lammi, Lauri ^e   Nieminen, Markku ^f   Poussa, Tuija ^g   Ranta, Arto ^h   Saarelainen, Seppo ^c   Salminen, Paulina ^b  

^a Terveystalo Hospital   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^e JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^f STAT Consulting ^*

^g NOKIA RESEARCH CENTER   (United States)

^h Hatanpää Hospital   (Finland)

Author keywords

Asthma; Esomeprazole; Fundoplication; Gastro oesophageal reflux; Hyperresponsiveness; Nitric oxide

Indexed keywords

ESOMEPRAZOLE; METHACHOLINE; NITRIC OXIDE; RENNIE;

ADULT; AGED; AIRWAY DYNAMICS; ARTICLE; ASTHMA; COMPARATIVE EFFECTIVENESS; COUGHING; DISEASE SEVERITY; DOSE RESPONSE; DYSPNEA; ESOPHAGEAL PH MONITORING; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG FLOW VOLUME CURVE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; STOMACH FUNDOPLICATION; TREATMENT DURATION; VISUAL ANALOG SCALE;

ASTHMA; ESOMEPRAZOLE; FUNDOPLICATION; GASTRO-OESOPHAGEAL REFLUX; HYPERRESPONSIVENESS; NITRIC OXIDE;

ADULT; AGED; ANTI-ULCER AGENTS; ASTHMA; BREATH TESTS; BRONCHIAL HYPERREACTIVITY; ESOMEPRAZOLE; FEMALE; FORCED EXPIRATORY VOLUME; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; TREATMENT OUTCOME;

EID: 84880156225     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12005     Document Type: Article

References (20)

1. Kiljander TO, Laitinen JO. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest. 2004;126: 1490-1494.
2. Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. 2000;162: 34-39.
3. Harding SM. Gastroesophageal reflux: a potential asthma trigger. Immunol Allergy Clin North Am. 2005;25: 131-148.
4. Chan WW, Chiou E, Obstein KL, Tignor AS, Whitlock TL. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. Arch Intern Med. 2011;171: 620-629.
5. Tutuian R, Mainie I, Agrawal A, Adams D, Castell DO. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006;130: 386-391.
6. Kiljander TO, Salomaa ER, Hietanen EK, Ovaska J, Helenius H, Liippo K. Gastroesophageal reflux and bronchial responsiveness: correlation and the effect of fundoplication. Respiration. 2002;69: 434-439.
7. Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med. 1996;100: 395-405.
8. Kiljander T, Salomaa ER, Hietanen E, Helenius H, Liippo K, Terho EO. Asthma and gastroesophageal reflux: can the response to anti-reflux therapy be predicted? Respir Med. 2001;95: 387-392.
9. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med. 1991;85(Suppl. B): 25-31.
10. Rantanen TK, Salo JA, Salminen JT, Kellokumpu IH. Functional outcome after laparoscopic or open Nissen fundoplication: a follow-up-study. Arch Surg. 1999;134: 240-244.
11. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide in adults and children. Am J Respir Crit Care Med. 1999;160: 2104-2117.
12. Nieminen MM. Unimodal distribution of bronchial hyperresponsiveness to methacholine in asthmatic patients. Chest. 1992;102: 1537-1543.
13. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine: an approach suitable for population studies. Am Rev Respir Dis. 1987;136: 1412-1417.
14. Littner MR, Leung FW, Ballard ED, Huang B, Samra NK. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005;128: 1128-1135.
15. Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, Illueca M, Beckman O, Sostek MB. Effects of esomeprazole 40mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2006;173: 1091-1097.
16. Kiljander TO, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40mg once or twice daily on asthma. Am J Respir Crit Care Med. 2010;181: 1042-1048.
17. The American Lung Association Asthma Clinical Research Centers. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360: 1487-1499.
18. Bagnato GF, Gulli S, Giacobbe O, De Pasquale R, Purello D'Ambrosio F. Bronchial hyperresponsiveness in subjects with gastroesophageal reflux. Respiration. 2000;67: 507-509.
19. Jansen DF, Timens W, Kraan J, Rijken B, Postma DS. (A)Symptomatic bronchial hyper-responsiveness and asthma. Respir Med. 1997;91: 121-134.
20. Norrman E, Plaschke P, Björnsson E, Rosenhall L, Lundbäck B, Jansson C, Lindholm N, Boman G. Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden. Respir Med. 1998;92: 480-487.